Compound ID | 3406
MBK-01
Synonym(s): MBK 01 | MBK01
Class: Microbiome modulating agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Clostridioides difficile; indicated for recurrent C. difficile infection |
| Description: | Faecal microbiota transplant; effective treatment for patients without antibiotic pretreatment; superior to fidaxomicin as treatment to Clostridium difficile infection |
| Institute where first reported: | Mikrobiomik Healthcare Company |
| Year first mentioned: | 2022 |
| Highest developmental phase: | Phase 3 |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.